Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

Lancet Infectious Diseases

Volumn 7, Issue 10, 2007, Pages 658-666

  Simonsen, Lone ^a,c   Taylor, Robert J ^d   Viboud, Cecile ^b   Miller, Mark A ^b   Jackson, Lisa A ^e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d LTS Corporation   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

CLINICAL TRIAL; COHORT ANALYSIS; DEATH; GROUPS BY AGE; HUMAN; INCOME; INFLUENZA; INFLUENZA VACCINATION; MORTALITY; POLICY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; WINTER;

AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIALS; SEASONS; VACCINES, INACTIVATED;

EID: 34548847744     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70236-0     Document Type: Review

References (62)

1. Noble G. Epidemiological and clinical aspects of influenza (1982), CRC Press, Boca Raton
2. Nguyen-Van Tam J. Epidemiology of influenza (1998), Blackwell Science, Oxford
3. Thompson W., Shay D., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
4. Thompson W., Shay D., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
5. Simonsen L., Clarke M., Schonberger L., Arden N., Cox N., and Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178 (1998) 53-60
6. Simonsen L., Reichert T., Viboud C., Blackwelder W., Taylor R., and Miller M. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165 (2005) 265-272
7. Demicheli V., Rivetti D., Deeks J., and Jefferson T. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 3 (2004) CD001269.
8. Burney L. Influenza immunization. J Okla State Med Assoc 53 (1960) 830-833
9. Stuart W., Dull H., Newton L., McQueen J., and Schiff E. Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-66. JAMA 209 (1969) 232-238
10. Bridges C., Harper S., Fukuda K., Uyeki T., Cox N., and Singleton J. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 52 (2003) 1-34 CE1-4.
11. World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Resolution 56.19 (May 28, 2003). http://www.who.int/gb/ebwha/pdf_files/WHA56/ea56r19.pdf (accessed July 24, 2007).
12. Centers for Disease Control and Prevention. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or =65 years-United States, 1989-2001. MMWR Morb Mortal Wkly Rep 52 (2003) 958-962
13. Vu T., Farish S., Jenkins M., and Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20 (2002) 1831-1836
14. Gross P., Hermogenes A., Sacks H., Lau J., and Levandowski R. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
15. Rizzo C., Viboud C., Montomoli E., Simonsen L., and Miller M. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 24 (2006) 6468-6475
16. Glezen W., Greenberg S., Atmar R., Piedra P., and Couch R. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283 (2000) 499-505
17. Reichert T., Simonsen L., Sharma A., Pardo S., Fedson D., and Miller M. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 160 (2004) 492-502
18. Langmuir A., Henderson D., and Serfling R. The epidemiological basis for the control of influenza. Am J Public Health Nations Health 54 (1964) 563-571
19. Serfling R. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep 78 (1963) 494-506
20. Simonsen L., Clarke M., Williamson G., Stroup D., Arden N., and Schonberger L. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 87 (1997) 1944-1950
21. Bridges C., Thompson W., Meltzer M., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 (2000) 1655-1663
22. Fedson D., and Nichol K. Should we question the benefits of influenza vaccination for the elderly?. Infect Dis News 18 (2005) 6-8
23. Watt J., Levine O., and Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr 143 suppl (2003) S163-S187
24. Kelly H., Vu T., and Smith D. Influenza vaccination and mortality in the United States. Arch Intern Med 165 (2005) 2037-2038
25. Wongsurakiat P., Maranetra K., Gulprasutdilog P., et al. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study. Respirology 9 (2004) 550-556
26. Allsup S., Haycox A., Regan M., and Gosney M. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine 23 (2004) 639-645
27. Govaert T., Thijs C., Masurel N., Sprenger M., Dinant G., and Knottnerus J. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 (1994) 1661-1665
28. Praditsuwan R., Assantachai P., Wasi C., Puthavatana P., and Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 88 (2005) 256-264
29. Goronzy J., Fulbright J., Crowson C., Poland G., O'Fallon W., and Weyand C. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75 (2001) 12182-12187
30. Kang I., Hong M., Nolasco H., et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 173 (2004) 673-681
31. Vallejo A. Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol Med 13 (2007) 94-102
32. Govaert T., Sprenger M., Dinant G., Aretz K., Masurel N., and Knottnerus J. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 12 (1994) 1185-1189
33. Goodwin K., Viboud C., and Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 (2005) 1159-1169
34. Halloran M., and Longini Jr. I. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol 154 (2001) 391-398
35. Scharfstein D., Halloran M., Chu H., and Daniels M. On estimation of vaccine efficacy using validation samples with selection bias. Biostatistics 7 (2006) 615-629
36. Rivetti D., Jefferson T., Thomas R., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3 (2006) CD004876.
37. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., and Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366 (2005) 1165-1174
38. Armstrong B., Mangtani P., Fletcher A., et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ 329 (2004) 660
39. Jackson L., Jackson M., Nelson J., Neuzil K., and Weiss N. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35 (2006) 337-344
40. Jackson L., Nelson J., Benson P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35 (2006) 345-352
41. Mangtani P., Cumberland P., Hodgson C., Roberts J., Cutts F., and Hall A. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 190 (2004) 1-10
42. Nordin J., Mullooly J., Poblete S., et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 184 (2001) 665-670
43. Glezen W., and Simonsen L. Commentary: benefits of influenza vaccine in US elderly-new studies raise questions. Int J Epidemiol 35 (2006) 352-353
44. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 333 (2006) 912-915
45. Fedson D., Wajda A., Nicol J., and Roos L. Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983. Ann Intern Med 116 (1992) 550-555
46. Bratzler D., Houck P., Jiang H., et al. Failure to vaccinate Medicare inpatients: a missed opportunity. Arch Intern Med 162 (2002) 2349-2356
47. Vaupel J., and Yashin A. Heterogeneity's ruses: some surprising effects of selection on population dynamics. Am Stat 39 (1985) 176-185
48. Gross P., Quinnan G., Rodstein M., et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med 148 (1988) 562-565
49. Nichol K. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults (1998), Blackwell Science, Oxford
50. Nichol K. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21 (2003) 1769-1775
51. Voordouw A., Sturkenboom M., Dieleman J., et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 292 (2004) 2089-2095
52. Smith S., Demicheli V., Di Pietrantonj C., et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 1 (2006) CD004879.
53. Patriarca P., Weber J., Parker R., et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 253 (1985) 1136-1139
54. Falsey A., Hennessey P., Formica M., Cox C., and Walsh E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352 (2005) 1749-1759
55. Simonsen L., and Viboud C. Respiratory syncytial virus infection in elderly adults. N Engl J Med 353 (2005) 422-423
56. Hall G. Antiflu, or antideath vaccination?. Lancet 357 (2001) 2141
57. Minutello M., Senatore F., Cecchinelli G., et al. Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine 17 (1999) 99-104
58. Keitel W., Atmar R., Cate T., et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 166 (2006) 1121-1127
59. Treanor J., Mattison H., Dumyati G., et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 117 (1992) 625-633
60. Wright P. Does oseltamivir work against influenza B?. Clin Infect Dis 44 (2007) 203
61. Glezen W. Influenza control. N Engl J Med 355 (2006) 79-81
62. Halloran M., and Longini Jr. I. Public health. Community studies for vaccinating schoolchildren against influenza. Science 311 (2006) 615-616